Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.70−0.17 (-8.85%)
Close on Nov 18, 2026Market cap $30.81MP/E –Yield –
Alterity Therapeutics net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2023 it was A$13.81M, up 7.5% from the year before. The highest annual figure on record is A$15.31M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | A$13.81M | +7.5% |
| FY2022 | Jun 30, 2022 | A$12.85M | -16.1% |
| FY2021 | Jun 30, 2021 | A$15.31M | +13.8% |
| FY2020 | Jun 30, 2020 | A$13.46M | +9.1% |
| FY2019 | Jun 30, 2019 | A$12.34M | – |
See a number that looks wrong?